Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Located at 4001 E
Beyond glycemic endpoints, GLP-1s are being evaluated for cardiometabolic and neuroprotective roles, expanding their use across specialties (Nauck & Meier, 2020
But in recent months, studies have shown that these popular medications can have numerous other health benefits
September 2025: Another Study Says Ozempic Increases Risk of Vision Loss A study published in the Journal of the American Medical Association (JAMA) has concluded that taking semaglutide drugs like Ozempic raises the risk of a certain type of blindness by 1.76 times
From 2019 to 2024, the percentage of patients prescribed one of these three GLP-1 drugs increased from .03 to .68 percenta staggering 2,029% increase
